Page last updated: 2024-12-08

11-deoxytetrodotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

**11-Deoxytetrodotoxin (11-deoxyTTX)** is a structural analog of tetrodotoxin (TTX), a potent neurotoxin produced by various marine organisms like pufferfish.

**Key Features and Importance for Research:**

* **Structural Similarity to TTX:** 11-deoxyTTX shares a similar structure to TTX, with the key difference being the absence of a hydroxyl group at the 11-position. This structural similarity allows it to bind to the same target site as TTX, the voltage-gated sodium channels (VGSCs) in nerve cells.

* **Reduced Toxicity:** Compared to TTX, 11-deoxyTTX is significantly less toxic. This reduced toxicity makes it a valuable tool for research purposes.

* **Investigating VGSC Function:** 11-deoxyTTX is used as a probe to investigate the structure-function relationship of VGSCs. By comparing the effects of 11-deoxyTTX and TTX on neuronal activity, researchers can gain insights into the role of specific amino acid residues within the VGSC binding site.

* **Developing Therapeutics:** The reduced toxicity of 11-deoxyTTX has prompted research into its potential as a therapeutic agent. Studies are underway to explore its use in treating conditions like chronic pain, epilepsy, and neurological disorders.

* **Studying TTX Biosynthesis:** Understanding the biosynthesis of TTX is crucial for elucidating its toxic mechanisms and for developing strategies to mitigate its effects. 11-deoxyTTX serves as an intermediate in the biosynthesis of TTX, and its study provides valuable information about the enzymatic pathways involved.

**Overall, 11-deoxyTTX is a valuable research tool that provides insights into the structure, function, and biosynthesis of TTX. Its reduced toxicity compared to TTX makes it a promising candidate for therapeutic development.**

11-deoxytetrodotoxin: RN given refers to parent cpd; isolated from the newt Cynops ensicauda [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163911
CHEBI ID196242
MeSH IDM0176704

Synonyms (7)

Synonym
11-deoxytetrodotoxin
tetrodoxin, 11-deoxy-, (4beta)-
113564-23-1
CHEBI:196242
(1r,5s,6r,7r,9s,11s,13s,14s)-3-amino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol
C20026
DTXSID601019777
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic heteromonocyclic compound
organonitrogen heterocyclic compoundAny organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.76 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]